Proposed inspection measures in China could have serious implications for foreign drug manufacturers
This article was originally published in SRA
Executive Summary
China's State Food and Drug Administration is seeking feedback on proposed regulations for administering inspections of foreign drug manufacturers that, if adopted, will have serious implications for overseas companies that import or apply to import drugs to China1,2.